Stay updated on IMGN779 in CD33+ AML: Clinical Trial
Sign up to get notified when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.

Latest updates to the IMGN779 in CD33+ AML: Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. This is a minor page update and does not affect the study details presented on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated to v3.3.4 on the page, replacing the previous v3.3.3.SummaryDifference0.1%

- Check48 days agoChange DetectedLocations section reorganized: a unified 'Locations' section was added and state-specific location headings were removed. The revision updated from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check77 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding lapse notice about updates and operating status has been removed from the page. The rest of the study details (title, conditions, design, locations, and outcome measures) remain unchanged.SummaryDifference0.4%

- Check106 days agoChange DetectedNo significant changes detected on the Study Details page; the core information and page structure remain consistent with the prior version.SummaryDifference0.4%

Stay in the know with updates to IMGN779 in CD33+ AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.